首页|参红宁心方颗粒治疗不稳定型心绞痛临床疗效及对炎性因子的影响

参红宁心方颗粒治疗不稳定型心绞痛临床疗效及对炎性因子的影响

扫码查看
目的 观察参红宁心方颗粒治疗冠心病不稳定型心绞痛临床疗效及对炎性因子[C反应蛋白(CRP)、人基质金属蛋白酶(MMP-9)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]的影响。探讨不稳定型心绞痛的中医机制及临床用药。方法 收集医院60例冠心病不稳定型心绞痛患者随机归入治疗组和对照组,对照组根据指南采用常规西药方案治疗,治疗组则是在西药常规基础治疗上联合参红宁心方颗粒,观察两组治疗前后心绞痛发作率、硝酸甘油停减率、心电图改善情况、中医证候积分、血脂指标及炎性因子水平变化情况。结果 治疗组在心绞痛发作和中医证候积分方面,与对照组比较,差异有统计学意义(P<0。05),治疗组优于对照组。在改善炎性因子(hs-CRP、MMP-9、IL-6、TNF-α)水平方面,治疗组均明显优于对照组(P<0。05)。两组血脂指标比较,治疗组优于对照组,差异有统计学意义(P<0。05);心电图ST段疗效,治疗组总有效率为86。67%(26/30),对照组的76。67%(23/30),治疗组与对照组比较,差异有统计学意义(P<0。05)。硝酸甘油停减情况比较,治疗组患者停减率为83。33%(25/30),对照组患者停减率为63。34%(19/30),治疗组与对照组相比,差异有统计学意义(P<0。05)。结论 参红宁心方颗粒联合常规西药治疗冠心病不稳定型心绞痛,可明显减少心绞痛发作,改善临床症状,有效改善炎性因子水平,有利于改善心脏功能,提高临床疗效,改善患者生活质量,且用药后安全性可靠。
Effect of Shenghong Ningxinfang Granules(参红宁心方颗粒)in Treatment of Unstable Angina(UA)and Influence on Inflammatory Factors
Objective To observe the clinical efficacy and effect of Shenghong Ningxinfang Granules(参红宁心方颗粒)on coronary heart disease unstable angina pectoris and the effects on inflammatory factors[C-reactive protein(CRP),human matrix metalloproteinase(MMP-9),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)].To explore the TCM mechanism and clinical use of unstable angina.Method A total of 60 patients with unstable angina pectoris with coronary heart disease were randomly classified into the treatment group and the control group,and the control group was treated with conventional western medicine regimen according to the guidelines,and the treatment group was combined with Shenghong Ningxinfang Granules on the conventional basic treatment of western medicine,and the study observed the angina attack rate,nitroglycerin stop reduction rate,electrocardiogram improvement,TCM certificate score,blood lipid index and inflammatory factor level changes before and after treatment in the two groups.Results There was a statistically significant difference in terms of angina attack and TCM certificate score between the treatment group and the control group(P<0.05),and the treatment group was better than the control group.In terms of improving the levels of inflammatory factors(hs-CRP,MMP-9,IL-6,TNF-α),the treatment group was significantly better than the control group(P<0.05).The lipid indexes of the treatment group were better than those of the control group,and the difference was statistically significant(P<0.05).The total effective rate of ST segment of electrocardiogram(ECG)was 86.67%(26/30)in the treatment group and 76.67%(23/30)in the control group,and the difference between the treatment group and the control group was statistically significant(P<0.05).The cessation rate of nitroglycerin of the patients in the treat-ment group was 83.33%(25/30),and that of the control group was 63.34%(19/30),and the difference between the treatment group and the control group was statistically significant(P<0.05).Conclusion The combination of Shenghong Ningxinfang Gran-ules with conventional western medicine for the treatment of unstable angina pectoris in coronary heart disease can significantly re-duce the angina attacks,improve the clinical symptoms,effectively improve the levels of inflammatory factors,help to improve the heart function,tje clinical efficacy and the quality of life of patients,and it is safe and reliable after medication.

Shenghong Ningxinfang Granules(参红宁心方颗粒)coronary heart diseaseunstable anginaeffect observation

师卿杰

展开 >

河南中医药大学第三附属医院,河南郑州 450000

参红宁心方颗粒 冠心病 不稳定型心绞痛 疗效观察

河南省中医药科学研究专项

20-21ZY2224

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(4)
  • 27